Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug

benzinga.com/trading-ideas/movers/25/06/45800081/dr-reddys-and-alvotech-join-hands-to-develop-biosimilar-for-mercks-blockbuster-cancer-drug

Alvotech (NASDAQ:ALVO) on Thursday collaborated with Dr. Reddy's Laboratories Ltd. (NYSE:RDY) to co-develop, manufacture and commercialize a biosimilar candidate to Keytruda (pembrolizumab) for global markets.
Merck & Co Inc's (NYSE:MRK) Keytruda (pembrolizumab) is indicated for numerous…

This story appeared on benzinga.com, 2025-06-05 17:56:50.
The Entire Business World on a Single Page. Free to Use →